Advertisement
Paper| Volume 40, ISSUE 6, P793-805, December 15, 1985

Influence of the thromboxane antagonist BM 13.177 on the irrachidonic acid-induced increase in pulmonary vascular resistance and permeability in rabbit lungs

  • W. Seeger
    Affiliations
    Clinical Phathophysiology and Experimental Medicine / Department of Internal Medicine; Department of Clinical Chemistry and Pathobiochemistry; Lustus-Liebig-University; Klinikstraβe 36, D-63 Gieβen, FRG
    Search for articles by this author
  • Ch. Ernst
    Affiliations
    Clinical Phathophysiology and Experimental Medicine / Department of Internal Medicine; Department of Clinical Chemistry and Pathobiochemistry; Lustus-Liebig-University; Klinikstraβe 36, D-63 Gieβen, FRG
    Search for articles by this author
  • D. Walmrath
    Affiliations
    Clinical Phathophysiology and Experimental Medicine / Department of Internal Medicine; Department of Clinical Chemistry and Pathobiochemistry; Lustus-Liebig-University; Klinikstraβe 36, D-63 Gieβen, FRG
    Search for articles by this author
  • H. Neuhof
    Affiliations
    Clinical Phathophysiology and Experimental Medicine / Department of Internal Medicine; Department of Clinical Chemistry and Pathobiochemistry; Lustus-Liebig-University; Klinikstraβe 36, D-63 Gieβen, FRG
    Search for articles by this author
  • L. Roka
    Affiliations
    Clinical Phathophysiology and Experimental Medicine / Department of Internal Medicine; Department of Clinical Chemistry and Pathobiochemistry; Lustus-Liebig-University; Klinikstraβe 36, D-63 Gieβen, FRG
    Search for articles by this author
      This paper is only available as a PDF. To read, Please Download here.

      Abstract

      In blood-free perfused isolated rabbit lungs increased availability of free arachidonic acid (AA), whether exogenously applied or released from the endogenous membrane phospholipid pool after different stimuli, causes an acute pulmonary artery pressor response and an increase in vascular permeability. Previous experiments suggested that the vasoconstriction is caused primarily by the cyclooxygenase product thromboxane (Tx) A2, whereas an increase in the capillary filtration coefficient must be ascribed to non-cyclooxygenase produts of AA. The influence of BM 13.177, a non-prostanoic antagonist of TxA2− and endoperoxide-effects in platelets, on the AA-induced vascular effects in isolated rabbit lungs was investigated. BM 13.177 dose-dependently inhibited the pressor responses evoked by repetitive direct application of AA (IC50 ∼ 10−6 M) or by repetitive stimulation of endogenous AA-release with the calcium ionophore A 23187 (IC50 ∼ 10−7M), with maximum reduction of the pressor responses to < 15 %. The generation of TxA2 and of prostaglandin (PG)I2 evoked by these stimuli was, however, not altered. At a concentration of 10−5 M BM 13.177 did not influence the capillary filtration coefficient, measured during venous pressure challenge, under baseline conditions and after stimulation with AA in presence of indomethacin. Conclusion: βM 13.177 acts as TxA2/endoperoxide antagonist with dose-dependent inhibition of AA-induced vasoconstriction in the pulmonary vascular bed.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Thrombosis Research
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Wicks T.C.
        • Rose J.C.
        • Johnson M.
        • Ramwell P.W.
        • Kot P.A.
        Vascular responses to arachidonic acid in the perfused canine lung.
        Circ. Res. 1976; 38: 167-171
        • Spannhake E.W.
        • Hyman A.L.
        • Kadowitz P.J.
        Dissimilar in vivo effects of arachidonic acid on the canine pulmonary vascular bed and airways.
        Adv. Prost. Thromb. Res. 1980; 7: 937-941
        • Seeger W.
        • Wolf H.
        • Stahler G.
        • Neuhof H.
        • Roka L.
        Increased pulmonary vascular resistance and permeability due to arachidonate metabolism in isolated rabbit lungs.
        Prostaglandins. 1982; 23: 157-173
        • Seeger W.
        • Wolf H.
        • Neuhof H.
        • Roka L.
        Release and oxygenation of arachidonic acid: nonspecific triggering and pathophysiological consequences in isolated rabbit lungs.
        Adv. Prost. Thromb. Res. 1983; 12: 99-105
        • Littner M.R.
        • Kazmi G.M.
        • Lott P.D.
        Inhibition of cyclooxygenase production does not prevent arachidonate from increasing extravascular lung water and albumin in isolated dog lung.
        Prostagl. Leukotr. Med. 1984; 15: 53-68
        • Malik A.B.
        • Perlman M.B.
        • Cooper J.A.
        • Noonan T.
        • Bizios R.
        Pulmonary microvascular effects of arachidonic acid metabolites and their role in lung vascular injury.
        in: Fed. Proc.44. 1985: 36-42
        • Townsley M.I.
        • Korthuis R.J.
        • Taylor A.E.
        Effects of arachidonate on permeability and resistance distribution in canine lungs.
        J. appl. Physiol. 1985; 58: 206-210
        • Seeger W.
        • Bauer M.
        • Bhakdi S.
        Staphylococcal alpha-toxin elicits hypertension in isolated rabbit lungs.
        in: Evidence for thromboxane formation and the role of extracellular calcium. J. Clin. Invest.74. 1984: 849-858
        • Palmer M.A.
        • Piper P.J.
        • Vane J.R.
        Release of rabbit aorta contracting substance and prostaglandins induced by chemical or mechanical stimulation of guinea-pig lungs.
        Br. J. Pharm. 1973; 49: 226-242
        • Uotila P.
        • Hiltunen A.
        • Makila K.
        • Mannisto J.
        • Toivonen H.
        • Hartiala J.
        The metabolism of arachidonic acid in isolated hamster, rat and guinea pig lungs.
        Prostagland. Med. 1980; 5: 149-162
        • Folco G.C.
        • Omini C.
        • Vigano T.
        • Iantorno G.
        • Berti F.
        Pharmacologic control of thromboxane A2 generation in lungs.
        Adv. Prost. Thromb. Res. 1980; 7: 917-925
        • Al-Ubaidi F.
        • Bakhle Y.S.
        Differences in biological activation of arachidonic acid in perfused lungs from guinea pig, rat and man.
        Eur. J. Pharmacol. 1980; 62: 89-96
        • Korbut R.
        • Boyd J.
        • Eling T.
        Prostcyclin and thromboxane A2 release in isolated rat lungs.
        Prostaglandins. 1982; 23: 67-75
        • Littner M.
        • Kazmi G.
        • Lott F.
        • Golub M.
        • Berger M.
        Cyclooxygenase products and cyclic nucleotide levels with infusion of arachidonic acid, PGI, PGE1, PGF2, and 6-keto PGF1 in isolated dog lung.
        Am. Rev. Resp. Dis. 1983; 128: 268-287
        • Robinson C.
        • Hoult J.R.
        • Waddell K.A.
        • Blair I.A.
        • Dollery C.T.
        Total profiling by GC/NICIMS of the major cyclooxygenase-products from antigen and leukotriene-challenged guinea pig lung.
        Biochem. Pharmacol. 19841; 33: 395-400
        • Nandiwada P.A.
        • Hyman A.L.
        • Spannhake E.W.
        • Kadowitz P.J.
        Pulmonary vascular responses to thromboxane A as unmasked by OKY-1581, a novel inhibitor of thromboxane synthesis (Abstract).
        Am. Rev. Resp. Dis. 1982; 125: 281
        • Maddox Y.
        • Cunard C
        • Ramwell P.
        A comparison of the contractile responses of rodent and human pulmonary vascular segments to icosanoids (Abstract).
        in: Bailey J.M. Prostaglandins and Leukotrienes 84 - Abstract Volume. May 1984: 36 (Washington D.C.)
        • Kadowitz P.J.
        • Gruetter C.A.
        • Spannhake E.W.
        • Hyman A.L.
        pulmonary vascular responses to prostaglandins.
        in: Fed. Proc.40. 1981: 1991-1996
        • Seeger W.
        • Radinger H.
        • Neuhof H.
        Increase in the capillary filtration coefficient of isolated rabbit lungs due to non-cyclooxygenase pathway of arachidonic acid (Abstract).
        Microcirc. Clin. Exptl. 1984; 3: 351
        • Muller-Beckmann B.
        • Stegmeier K.
        • Schmitt W.
        • Patscheke H.
        Evidence for competitive antagonism of BM 13.177 to U-46619 (thromboxane-mimetic) induced constriction of rabbit aorta.
        IRCS Med. Sci. 1983; 11: 1100-1101
        • Patscheke H.
        • Stegmeier K.
        Investigations on a selective non-prostanoic thromboxane antagonist) BM 13.177, in human platelets.
        Thrombosis Res. 1984; 33: 277-288
        • Stegmeier K.
        • Pill J.
        • Müller-Beckmann B.
        • Schmidt F.H.
        • Witte E.C.
        • Wolff H.P.
        • Patscheke H.
        The pharmacological profile of the thromboxane A-antagonist BM 13.177, a new anti-platelet and anti-thrombotic drug.
        Thrombosis Res. 1984; 35: 379-395
        • Turner M.R.
        • Clough R.G.
        • Michel C.C.
        The effects of cationized ferritin and native ferritin upon the filtration coefficient of single frog capillaries.
        in: Evidence that proteins in the endothelial cell coat influence permeability. Microvasc. Res.25. 1983: 205-222
        • Haraldsson B.
        • Rippe B.
        Increases in albumin clearance in perfused rat hindquarters by removal of cell serum from the perfusate, with no change in vascular resistance, CFC or PS for CrEDTA (Abstract).
        Int. J. Microcirc. Clin. Exptl. 1984; 3: 353
        • Schneeberger E.E.
        Vascular transport across pulmonary capillary endothelium in the fluorocarbon exchange transfused rat (Abstract).
        Int. J. Microcirc. Clin. Exptl. 1984; 3: 415
        • Hofman W.F.
        • Erhart I.C.
        Permeability edema in dog lung depleted of blood components.
        J. appl. Physiol. 1984; 57: 147-153
        • Robinson C.
        • Peers S.H.
        • Waddell K.A.
        • Blair I.A.
        • Hoult J.R.S.
        Thromboxane B-uptake and metabolism in isolated perfused lung.
        in: Identification and comparison with prostaglandin F20. Biochim. Biophys. Acta. 712. 1982: 315-325
        • Wangensteen O.D.
        • Lysaker E.
        • Savaryn P.
        Pulmonary capillary filtration and reflection coefficients in the adult rabbit.
        Microvasc. Res. 1977; 14: 81-97
        • Unruh H.W.
        • Goldberg H.S.
        • Oppenheimer L.
        Pulmonary interstitial compartments and tissue resistance to fluid flux.
        J. appl. Physiol. 1984; 57: 1512-1519
        • Taylor A.E.
        • Gaar K.A.
        Calculation of equivalent pore radii of the pulmonary capillary and alveolar membranes.
        Res. Argent. Angiol. 1969; 111: 25-40
        • Gresele P.
        • Arnout J.
        • Janssens W.
        • Deckmyn H.
        • Lemmens J.
        • Vermylen J.
        BM 13.177, a selective blocker of platelet and vessel wall thromboxane receptors, is active in man.
        The Lancet, May. 1984; 5: 991-993
        • Heffner J.E.
        • Shoemaker S.A.
        • Canham E.M.
        • Patel M.
        • McMurtry I.F.
        • Morris H.G.
        • Repine J.E.
        Acetyl glycerol ether phosphorylcholine-stimulated human platelets cause pulmonary hypertension and edema in isolated rabbit lungs.
        J. Clin. Invest. 1983; 71: 351-357
        • Olanoff L.S.
        • Cook J.A.
        • Eller T.
        • Knapp D.R.
        • Halushka P.V.
        Protective effects of trans-13-APT, a thromboxane receptor antagonist, in endotoxemia.
        J. Cardiovasc. Pharmacol. 1985; 7: 114-120
        • Ogletree M.L.
        • Brigham K.L.
        Arachidonate raises vascular resistance but not permeability in lungs of awake sheep.
        J. appl. physiol. 1980; 48: 581-586
        • Seeger W.
        • Neuhof H.
        • Graubert E.
        • Wolf H.
        • Roka L.
        Comparative influence of the calcium-ionophorte A 23187, bradykinin, kallidin and eledoisin on the rabbit pulmonary vasculature with special reference to arachidonate metabolism.
        Adv. Exptl. Med. Biol. 1982; 156: 533-552
      1. SEEGER, W., NEUHOF, H., HALL, J. and WOLF, H. Circulating soluble fibrin as potent effector of thromboxane-mediated pulmonary vasoconstriction — new link between coagulation and AA-cascade. In press: Adv. Inflamm. Res.

        • Suttorp N.
        • Seeger W.
        • Schmidt F.
        • Simon L.S.
        • Neuhof H.
        • Roka L.
        Importance of the glutathione cycle in the defense of lung tissue against H2O2 attack (Abstract).
        Eur. J. Resp. Dis. suppl. 1983; 126: 473
        • Seeger W.
        • Stohr G.
        • Wolf H.
        • Neuhof H.
        Alteration of surfactant function due to protein leakage; special interaction with fibrinmonomer.
        J. appl. Physiol. 1985; 58: 326-338
        • Perkowski S.Z.
        • Havill A.M.
        • Flynn J.T.
        • Gee M.H.
        Role of intrapulmonary release of eicosanoids and superoxide anion as mediators of pulmonary dysfunction and endothelial injury in sheep with intermittent complement activation.
        Circ. Res. 1983; 53: 574-583
        • Brigham K.L.
        Metabolites of arachidonic acid in experimental lung vascular injury.
        in: Fed. Proc.44. 1985: 43-45
        • Utsunomiya T.
        • Krausz M.M.
        • Levine L.
        • Shepro D.
        • Hechtman H.B.
        Thromboxane mediation of cardiopulmonary effects of embolism.
        J. Clin. Invest. 1982; 70: 361-368
        • Weidner W.J.
        Effects of indomethacin on pulmonary hemodynamics and extravascular lung water in sheep after pulmonary microembolism.
        Prostaglandins Med. 1979; 3: 71-80
      2. NEUHOF, H., NOACK, A., HOFFMANN, CH. and SEEGER, W. Thromboxane mediated pulmonary vasoconstriction in rabbits induced by acute alveolar hypoxia. In press: 2 International Symposium on Prostaglandins. K.Schroer (Ed) Basel: Karger.